Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Lechat

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Therapie|November 1, 2012
[In Process Citation]Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Marion Bamberger, Nicholas Moore, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie|September 22, 2010
Comparators (medicinal and non medicinal) for marketing authorization, for public health, for payers and at the European levelDriss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Driss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
Fundamental & Clinical Pharmacology|July 14, 2005
Captopril-furosemide survival study in experimental heart failureNathalie Mougenot, Romain Bos, Odile Médiani, et al.
Clinical Pharmacokinetics|August 28, 2019
Comment on: "Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"Philippe Lechat, Jacques Ropers, Jérome Barré, et al.
American Heart Journal|February 9, 2002
Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol StudyAlain Leizorovicz, Philippe Lechat, Michel Cucherat, et al.
European Journal of Heart Failure|June 12, 2003
Beta-blocker benefit according to severity of heart failureAnissa Bouzamondo, Jean-Sébastien Hulot, Paola Sanchez, et al.
Fundamental & Clinical Pharmacology|March 30, 2007
Cell cycle arrest by oxaliplatin on cancer cellsSara William-Faltaos, Dany Rouillard, Philippe Lechat, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Therapie|November 1, 2012
[In Process Citation]Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Marion Bamberger, Nicholas Moore, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie|September 22, 2010
Comparators (medicinal and non medicinal) for marketing authorization, for public health, for payers and at the European levelDriss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Driss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
Fundamental & Clinical Pharmacology|July 14, 2005
Captopril-furosemide survival study in experimental heart failureNathalie Mougenot, Romain Bos, Odile Médiani, et al.
Clinical Pharmacokinetics|August 28, 2019
Comment on: "Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"Philippe Lechat, Jacques Ropers, Jérome Barré, et al.
American Heart Journal|February 9, 2002
Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol StudyAlain Leizorovicz, Philippe Lechat, Michel Cucherat, et al.
European Journal of Heart Failure|June 12, 2003
Beta-blocker benefit according to severity of heart failureAnissa Bouzamondo, Jean-Sébastien Hulot, Paola Sanchez, et al.
Fundamental & Clinical Pharmacology|March 30, 2007
Cell cycle arrest by oxaliplatin on cancer cellsSara William-Faltaos, Dany Rouillard, Philippe Lechat, et al.
Pageof 11